Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Earthgenes Pharmaceuticals LLC
Profile last edited on: 4/4/19      CAGE: 474G8      UEI:

Business Identifier: Metagenomic Library Screening for Novel Drug Candidates
Year Founded
2004
First Award
2005
Latest Award
2009
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

107 Cedar Street
Lexington, MA 02421
   (781) 862-3801
   info@earthgenes.com
   www.earthgenes.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Earthgenes Pharmaceuticals LLC has developed methods for cloning environmental DNA and expressing it in various hosts to discover novel antimicrobial drugs encoded in metagenomes. The firm offers superior methods for preparing large-insert metagenomic environmental bacterial libraries. Organzied around drug discovery through metagenomic technology, the firm appears to have discontinued operations entirely some time before 2014

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
1
Conversion Rate
33.33%
Phase I Dollars
$442,895
Phase II Dollars
$500,000
Total Awarded
$942,895

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2009 2 NSF $650,000
Project Title: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli Strain
2007 1 NIH $198,047
Project Title: Environmental DNA Natural Product Discovery Through An Engineered Host
2005 1 NIH $94,848
Project Title: Genetic tool to enhance natural product gene expression

Key People / Management

  Lance Davidow -- President

  Ian MacNeil

Company News

There are no news available.